| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
---
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
---
|
|
TheStreet.com
---
|
Fund Holdings
Nearly 65 percent of the fund’s stock portfolio was invested in North American companies, as of Sept. 30, 2010. Another 12 percent is in the United Kingdom. The vast majority of the fund’s portfolio is invested in developed market stocks, with only about 2 percent in emerging markets. Although the fund diversifies quite heavily among a number of industries, nearly 25 percent of assets were recently invested in the consumer goods sector. With only 32 stocks as of Sept. 30, 2010, the fund is considered extremely concentrated, which is usually viewed as aggressive, but its record reveals that its portfolio of high-dividend, high-quality value stocks provides less volatility.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 5.62 | 5.62 |
| Stocks | 73.96 | 73.96 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 20.43 | 20.43 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Eli Lilly and Company | LLY | 10.97 | 3.82 |
| ConocoPhillips | COP | 4.62 | 3.4 |
| Travelers Companies, Inc. | TRV | 17.74 | 3.23 |
| Raytheon Company | RTN | 8.08 | 3.22 |
| Johnson & Johnson | JNJ | 21.03 | 3.22 |
| Chevron Corp | CVX | 12.05 | 3.19 |
| Merck & Co Inc | MRK | 12.65 | 3.18 |
| Altria Group Inc. | MO | 16.92 | 3.17 |
| 3M Co | MMM | 13.28 | 3.13 |
| Kimberly-Clark Corporation | KMB | 23.3 | 3.11 |
